[./index.html]
[./company_overview.html]
[./team.html]
[./news.html]
[./employment.html]
[./technology.html]
[./research_services.html]
[./contact_us.html]
[#ANCHOR_Img1]
[./index.html]
[./partnering.html]
[../oc_therapeutic.html]
[Web Creator] [LMSOFT]
Copyright © 2011 Abeome Corp. All rights reserved.

Abeome and ArunA Biomedical Partner to Study Childhood Cancer
July 12, 2011
ArunA Biomedical, Inc. and Abeome Corporation, both Athens, Georgia based biotechnology companies, announced today they are recipients of a grant from CURE Childhood Cancer to study Medulloblastoma, the most common malignant central nervous system tumor in children. Read more

Abeome Awarded $244,479 Grant From the Federal Qualifying Therapeutic Discovery Project Program
November 2010
Abeome Corporation, a Georgia-based biotech company, today announced the award of a cash grant of $244,479 from the Federal Qualifying Therapeutic Discovery Project (QTDP) for its product pipeline in Ovarian Cancer.

Abeome Announces Collaboration with Medicago to Develop Neutralizing Monoclonal Antibodies for the H5N1 and H1N1 Influenza VLPs
March 2010
Abeome Corporation, a Georgia-based biotech company, today announced a collaboration with Medicago Inc. (TSX-V: MDG) to develop neutralizing monoclonal antibodies to Medicago's H5N1 and H1N1 VLPs using Abeome's patented DiSH (Direct Selection of Hybridoma) technology. Click here for additional details.